XTL Biopharmaceuticals Lt...
1.75
0.00 (0.00%)
At close: Jan 15, 2025, 10:16 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.37M 938.00K n/a n/a n/a 5.94M 907.00K 454.00K 3.20M 3.45M n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a 17.00 741.00K 380.00K n/a n/a n/a n/a 110.00K 54.00K 2.80M 3.30M n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a n/a n/a -17 1.63M 558.00K n/a n/a n/a 5.94M 797.00K 400.00K 400.00K 153.00K n/a n/a n/a
Operating Income -765.00K -880.00K -1.03M -948.00K -842.00K -793.00K -1.25M -2.56M -3.61M -2.02M -2.89M -2.36M -1.16M -1.26M 2.57M -9.59M -25.73M -16.05M -14.38M -16.78M 14.56M -17.71M -15.12M
Interest Income 36.00 36.00K 8.00K 33.00K 93.00K 87.00K 16.00K n/a n/a 10.00K 10.00K 43.00K 45.00K 2.00K 3.00K 317.00K 668.00K 1.06M 503.00K 352.00K 352.00K n/a n/a
Pretax Income -1.78M -1.35M 435.00K -782.00K -1.35M 2.99M -781.00K -2.54M -3.62M -2.12M -3.71M -1.74M -1.21M -1.26M 2.56M -9.28M -25.14M -14.90M -13.94M -16.42M -14.21M -17.11M n/a
Net Income -1.78K -1.35M 435.00K -782.00K -1.35M 2.99M -781.00K -2.54M -4.31M -2.53M -2.48M -1.39M -1.21M -1.26M 2.59M -9.25M -24.94M -15.13M -14.02M -16.47M -14.29M -17.14M -12.67M
Selling & General & Admin 734.00K 850.00K 1.00M 910.00K 807.00K 755.00K 1.19M 1.26M 1.41M 1.72M 3.67M 3.55M 1.00M 1.22M 2.43M 5.14M 5.58M 5.58M 5.46M 4.13M 3.10M 3.64M 3.00M
Research & Development 31.00K 30.00K 30.00K 38.00K 35.00K 38.00K 43.00K 443.00K 578.00K 278.00K 113.00K 99.00K 158.00K 64.00K n/a 10.39M 20.95M 10.87M 7.54M 12.79M 11.10M 13.16M 11.05M
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 765.00K 880.00K 1.03M 948.00K 842.00K 793.00K 1.25M 1.71M 2.00M 2.02M 3.85M 3.70M 1.16M 1.26M 2.29M 15.53M 26.53M 16.45M 13.00M 16.93M -14.56M 17.71M 15.12M
Interest Expense n/a n/a n/a n/a 29.00K n/a n/a n/a n/a n/a 35.00K 15.00K 8.00K n/a 2.00K 3.00K 4.00K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.69M 848.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 765.00K 880.00K 1.03M 948.00K 842.00K 793.00K 1.25M 1.71M 2.00M 2.02M 4.59M 4.08M 1.16M 1.26M 2.29M 15.53M 26.64M 16.50M 15.79M 20.23M -14.56M 17.71M 15.12M
Income Tax n/a 468.00K -1.47M -166.00K -69.00K -80.00K -457.00K 832.00K 2.31M 505.00K 458.00K -1.19M 6.00K n/a -23.00K -31.00K -206.00K 227.00K 78.00K 49.00K 78.00K 27.00K 12.67M
Shares Outstanding (Basic) 544.95M 544.91M 615.55M 514.21M 514.21M 514.21M 470.19M 274.04M 263.73M 231.22M 223.61M 217.69M 204.03M 113.40M 58.56M 58.55M 45.70M 40.35M 34.02M 26.95M 22.34M 22.23M 22.19M
Shares Outstanding (Diluted) 544.91M 544.91M 615.55M 514.21M 514.21M 514.21M 470.19M 274.04M 263.73M 231.22M 223.61M 217.69M 204.03M 113.40M 58.77M 58.55M 45.70M 40.35M 337.08M 274.53M 22.34M 22.23M 22.19M
EPS (Basic) n/a -0.00 0.00 -0.00 -0.00 0.01 -0.00 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.04 -0.16 -0.55 -0.38 -0.41 -0.61 -0.64 -0.77 -0.57
EPS (Diluted) n/a -0.00 0.00 -0.00 -0.00 0.01 -0.00 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.04 -0.16 -0.55 -0.38 -0.04 -0.06 -0.64 -0.77 -0.57
EBITDA -764.00K -879.00K -1.03M -947.00K n/a -792.00K -1.25M -1.71M -2.00M -1.97M -1.10M -3.80M -1.06M -1.21M 2.58M -18.40M -25.63M -15.80M -12.36M -16.46M 15.36M -17.71M -15.12M
Depreciation & Amortization 1K 1K 1K 1K 842.00K 1K 1K 3.00K 7.00K 53.00K 313.00K 136.00K 94.00K 42.00K 13.00K 39.00K 108.00K 243.00K 242.00K 319.00K 440.00K n/a n/a